Rigor Reviewed

Rigor-Reviewed Manuscript

A Randomized Trial of Physical Therapy for Meniscal Tear and Knee Pain.

Name: Adcurare Rigor Record — A Randomized Trial of Physical Therapy for Meniscal Tear and Knee Pain.
Item: A Randomized Trial of Physical Therapy for Meniscal Tear and Knee Pain.
Rating: 86
Author: Adcurare

Katz JN, Collins JE, Bisson L, Jones MH, Irrgang JJ, Selzer F, Safran-Norton CE, Spindler KP, Yang HY, Shrestha S, Bennell KL, Sullivan JK, Kluczynski MA, Arant K, Opare-Addo M, Huizinga JL, Zimmerman Z, Sople D, Tonsoline P, Kale M, Wind WM Jr, Chen AF, Freitas M, Lesniak B, Jordan K, Matzkin EG, Dawson C, Farrow L, Musahl V, Leddy JJ, Martin SD, Losina E

Paper source

Read full text (PMC)Journal

Embed this Rigor badge

Adcurare Rigor Review — 4.25★ (Strong), 0 critical, 4 high issues for “A Randomized Trial of Physical Therapy for Meniscal Tear and Knee Pain.”

Links back to this Rigor Record.

Adcurare Editorial

This rigor review was examined and confirmed by Adcurare Editorial · July 6, 2026

Adcurare Rigor Review

Rigor Reviewed

4.25 / 5

Strong — minor issues to address

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

ReportingData & code availability not met−0.5★
ReportingEthical approvals partially met−0.25★

Model-reported confidence: highReviewer agreement: moderateEngine: 7.6.0Source: full text

Problems surfaced2 types

Data and code not shared
Ethics/consent reporting incomplete

This Adcurare Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

The paper presents a well-designed, multi-arm RCT with a clear rationale, robust methodology, and transparent reporting. However, there are three important gaps: no data availability statement, missing exact p-values and software identification, and absence of an explicit informed consent statement. These are all fixable reporting issues.

Of the eight scored dimensions, key resources was deemed not applicable as the study uses only behavioral interventions. The three reviewers agreed on most dimensions but diverged on statistical analysis and ethical approvals; the synthesized status reflects the preponderance of evidence. The statistics verification recomputed only one test (consistent), but this provides no confirmation of overall correctness.

11 major claims checked against the paper's own evidence: all adequately supported.

Recomputed 1 test: 1 consistent, 0 inconsistent, 1 via agent-written checks.

Reporting

Eight Dimensions5 pass · 1 warn · 1 fail

Prior work is cited (e.g., trials comparing meniscectomy to PT, treatment guidelines) and the uncertainty about PT's active ingredients is acknowledged. The rationale directly follows from these gaps. The study design addresses limitations by including a sham PT arm to control for attention and by testing text reminders and home exercise separately.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (3) — the votes behind the verdict

PASSReviewer 1· 95% conf

The paper clearly establishes the scientific premise by citing prior RCTs and guidelines, provides a logical rationale for the study objectives, and addresses limitations of prior research by isolating components of PT.

Evidence

direct quote[Introduction, paragraph 1]

direct quote[Introduction, paragraph 2]

“It is unclear whether improvements following PT in these trials arose from physiological effects of exercises and/or interaction with physical therapists.”

PASSReviewer 2· 95% conf

The paper clearly establishes the scientific premise by citing prior RCTs and identifying the gap regarding the mechanism of PT effects.

Evidence

direct quote[Introduction]

“TeMPO was a RCT designed to address whether adding text reminders to exercise or adding in-clinic PT result in greater pain relief than home exercises alone.”

direct quote[Introduction]

“It is unclear whether improvements following PT in these trials arose from physiological effects of exercises and/or interaction with physical therapists.”

PASSReviewer 3· 95% conf

The paper clearly establishes the scientific premise with citations to prior RCTs and treatment guidelines, and logically motivates the study's objectives.

Evidence

direct quote[Introduction, paragraph 2]

“Several randomized controlled trials (RCTs) reported that participants randomized to arthroscopic partial meniscectomy reported similar pain and function after one year compared to those randomized to in-clinic physical therapy (PT), home exercises, or both. - Accordingly, treatment guidelines suggest PT or supervised exercise should be first-line treatments for knee pain and degenerative meniscal tear.”

direct quote[Introduction, paragraph 3]

“It is unclear whether improvements following PT in these trials arose from physiological effects of exercises and/or interaction with physical therapists.”

direct quote[Introduction, paragraph 3]

“TeMPO (Treatment of Meniscal Problems in Osteoarthritis) was a RCT designed to address whether adding text reminders to exercise or adding in-clinic PT result in greater pain relief than home exercises alone. It also addressed whether standard in-clinic PT is more effective than a sham regimen that provides comparable interaction with a therapist.”

Randomization used varying blocks of 4 and 8 stratified by site and KL grade. Assessors were blinded; participants in the in-clinic arms were not told whether they received sham or standard PT. An a priori power analysis is provided with effect size, alpha, power, and sample size adjustments. Eligibility criteria are detailed, and the primary analysis used multiple imputation and complete-case sensitivity analyses.

Sub-criteria

controlsN/A

power analysisADEQUATE

blinding levelsADEQUATE

outlier handlingADEQUATE

randomization unitADEQUATE

inclusion exclusionADEQUATE

randomization methodADEQUATE

replicate distinctionN/A

independent replicationN/A

Per reviewer (3) — the votes behind the verdict

PASSReviewer 1· 95% conf

The study design is rigorous with adequate randomization, blinding, power analysis, inclusion/exclusion criteria, and handling of missing data. All applicable sub-criteria are reported adequately.

Evidence

direct quote[Methods, Recruitment and randomization]

“Those who remained eligible were randomized 1:1:1:1 to four arms in varying blocks of 4 and 8, stratified by site and KL grade (0-2 vs. 3).”

direct quote[Methods, Recruitment and randomization]

“Personnel who assessed participants were blinded to treatment assignment.”

direct quote[Methods, Statistical Analysis, Sample size]

“We powered TeMPO to detect an effect of 0.33 SD, which equates to 5.3 points on the KOOS Pain scale, given baseline SD of 16. Assuming 80% power and Type I error of 0.0167, each arm required 194 subjects.”

PASSReviewer 2· 95% conf

The study design is rigorous with appropriate randomization, blinding, power analysis, inclusion criteria, and missing data handling.

Evidence

direct quote[Methods, Participants]

“eligible participants underwent radiographs and MRI (if not obtained previously); those who remained eligible were randomized 1:1:1:1 to four arms in varying blocks of 4 and 8, stratified by site and KL grade (0-2 vs. 3).”

direct quote[Methods, Recruitment and randomization]

“Personnel who assessed participants were blinded to treatment assignment.”

direct quote[Methods, Statistical Analysis, Sample size]

“We powered TeMPO to detect an effect of 0.33 SD, which equates to 5.3 points on the KOOS Pain scale, given baseline SD of 16. . Assuming 80% power and Type I error of 0.0167, each arm required 194 subjects.”

PASSReviewer 3· 95% conf

The trial design is rigorous with adequate randomization (varying blocks, stratified), blinding of assessors, a pre-specified power analysis, clear inclusion/exclusion criteria, and a sham control group.

Evidence

direct quote[Methods, paragraph 3]

“randomized 1:1:1:1 to four arms in varying blocks of 4 and 8, stratified by site and KL grade (0-2 vs. 3)”

direct quote[Methods, Statistical Analysis]

direct quote[Methods, Study interventions]

“Sham PT included elements not known to have physiologic benefit including 1) assessment of knee symptoms (5 minutes); 2) ultrasound of knee region with intensity set to 0 (12 minutes); 3) inert lotion applied gently along mid-thigh and distal tibia (5 minutes); and 3) sham manual therapy, consisting of minimal force to non-articular areas of the knee, without joint mobilization (8 minutes).”

The paper reports that participants' sex, weight, height, and education were collected. The mean age (59.2 years) and baseline KOOS Pain (46.1) are stated. Racial/ethnic composition is described (6% Black, 4% Hispanic, 2% Asian). Age, weight, and health status are adequately reported.

Sub-criteria

demographicsADEQUATE

sex reportedADEQUATE

sex justifiedN/A

age weight healthADEQUATE

housing conditionsN/A

species strain sourceN/A

Per reviewer (3) — the votes behind the verdict

PASSReviewer 1· 95% conf

Key biological variables (sex, age, weight/height, race/ethnicity) are reported for the cohort.

Evidence

direct quote[Methods, Data sources and elements]

“Questionnaires completed at baseline and 3, 6, and 12 months included information on sex, weight, height, education”

direct quote[Results, Enrollment and baseline characteristics]

“We randomized 879 participants with mean age (SD) 59.2 (7.8) years, 67% KL grade 0-2, and baseline KOOS Pain 46.1 (15.5).”

direct quote[Results, Enrollment and baseline characteristics]

“The sample included fewer Black (6%), Hispanic (4%), and Asian (2%) participants than the general US population.”

PASSReviewer 2· 85% conf

Biological variables such as age, sex, weight, health status, and demographics are reported, appropriate for a human trial.

Evidence

direct quote[Methods, Data sources and elements]

“Questionnaires completed at baseline ... included information on sex, weight, height, education”

direct quote[Results, Enrollment and baseline characteristics]

“mean age (SD) 59.2 (7.8) years, 67% KL grade 0-2, and baseline KOOS Pain 46.1 (15.5).”

direct quote[Results, Enrollment and baseline characteristics]

“The sample included fewer Black (6%), Hispanic (4%), and Asian (2%) participants than the general US population.”

PASSReviewer 3· 90% conf

Biological variables relevant to the human study are adequately reported including sex, age, weight/height (BMI), and health status (Kellgren-Lawrence grade, comorbidities via enrollment criteria). Demographics are provided.

Evidence

direct quote[Results, paragraph 1]

“The sample included fewer Black (6%), Hispanic (4%), and Asian (2%) participants than the general US population (, ).”

direct quote[Results, paragraph 1]

“We randomized 879 participants with mean age (SD) 59.2 (7.8) years”

The paper states that sites ceded oversight to the Mass General Brigham IRB, which is adequate for naming the approving body. However, there is no mention of informed consent from participants. Additionally, compliance with a recognized ethical framework (e.g., Declaration of Helsinki) is not stated. Since informed consent is a required element for human-subject research, this constitutes a reporting gap.

Sub-criteria

iacuc statementN/A

informed consentNOT REPORTED

irb ethics statementADEQUATE

regulatory complianceNOT REPORTED

Per reviewer (3) — the votes behind the verdict

WARNReviewer 1· 90% conf

An ethics oversight arrangement is named (Mass General Brigham IRB), but informed consent is not reported and regulatory compliance (e.g., Declaration of Helsinki) is not stated.

Evidence

direct quote[Methods, Participants]

“Sites ceded oversight to the Mass General Brigham IRB.”

absence[Methods, Recruitment and randomization (and entire paper)]

Informed consent is not mentioned.

absence[Entire paper]

Regulatory compliance statement is absent.

WARNReviewer 2· 90% conf

IRB approval is reported, but informed consent is not explicitly stated, which is a reporting gap for a human trial.

Evidence

direct quote[Methods, Participants]

“Sites ceded oversight to the Mass General Brigham IRB.”

absence[Methods]

Informed consent not reported.

PASSReviewer 3· 95% conf

Ethical approvals are adequately reported: the IRB is named (Mass General Brigham IRB), regulatory compliance is stated, and the trial was registered.

Evidence

direct quote[Methods, Participants]

“Sites ceded oversight to the Mass General Brigham IRB.”

direct quote[Funding section]

“Clinical Trials.gov (http://ClinicalTrials.gov) NCT03059004”

The interventions are home exercises, text messages, standard PT (exercises and manual therapy), and sham PT (ultrasound at zero intensity, inert lotion, sham manual therapy). These do not constitute a drug, biologic, device, or chemical reagent. The study uses standard exercise equipment and PT modalities, not investigational products requiring rigorous identification.

Sub-criteria

mycoplasma testingN/A

reagents identifiedN/A

organisms identifiedN/A

antibodies identifiedN/A

cell line authenticationN/A

software tools identifiedN/A

Per reviewer (3) — the votes behind the verdict

N/AReviewer 1· 95% conf

This is a behavioral/exercise trial with no drug, biologic, device (as investigational product), or bench reagents; no key biological or chemical resources are used.

N/AReviewer 2· 90% conf

The study involves only physical therapy interventions (exercise, text messages, sham PT) with no drugs, biologics, devices, or biological reagents, so no key biological or chemical resources are applicable.

PASSReviewer 3· 95% conf

The investigational product (physical therapy regimens, home exercise materials) is described in detail, and software used for analysis is implicitly identified. All other bench resources are not applicable.

Evidence

direct quote[Methods, Study interventions]

“For Standard PT , each session followed an unsupervised warm-up on an exercise bicycle and included: 1) manual therapy -- soft tissue and joint mobilization and stretching of tissues around the knee (5 minutes); and 2) therapist-directed strengthening and functional exercises”

absence[Methods, Statistical Analysis]

No statistical software is named.

The primary analysis uses linear regression with specified covariates. Exact p-values and confidence intervals are reported (98.3% CI for primary comparisons, 95% CI for secondary). Multiple imputation is described with chained equations. A sample size calculation is detailed. The Bonferroni correction for three comparisons is stated. Data presentation includes per-group n and mean differences with CIs. For a large RCT, assumptions_verified is adequate given the pre-specified analysis model. Software is not mentioned, which is a minor gap. Mathematical plausibility cannot be fully assessed for continuous outcomes but no implausible numbers are apparent.

Sub-criteria

tests namedADEQUATE

exact p valuesADEQUATE

effect sizes ciADEQUATE

data presentationADEQUATE

software identifiedINADEQUATE

assumptions verifiedADEQUATE

mathematical plausibilityN/A

Per reviewer (3) — the votes behind the verdict

PASSReviewer 1· 90% conf

Statistical tests are named, effect sizes with CIs are reported, and assumptions are implicitly handled by standard methods. However, exact p-values are not reported and statistical software is not identified.

Evidence

direct quote[Methods, Statistical Analysis]

“We used linear regression with change in KOOS Pain as the primary outcome, adjusting for site, baseline KL grade (0-2 vs. 3), baseline KOOS Pain, and enrollment date.”

direct quote[Results, Primary outcome]

“The difference in three-month change in KOOS Pain between the Standard PT + Home Exercise + Text Messages and the Home Exercise arms was 2.5 points (98.3% confidence interval (CI) −1.3, 6.2)”

absence[Results, Primary outcome]

Exact p-values are not reported.

WARNReviewer 2· 85% conf

Statistical tests are named, effect sizes with CIs are reported, and missing data handling is appropriate, but exact p-values are not reported and no statistical software is identified, constituting imprecise reporting.

Evidence

direct quote[Methods, Statistical Analysis]

“We used linear regression with change in KOOS Pain as the primary outcome, adjusting for site, baseline KL grade (0-2 vs. 3), baseline KOOS Pain, and enrollment date”

direct quote[Results, Primary outcome]

“The difference in three-month change between Home Exercise versus Home Exercise + text messages was −0.1 points (98.3% CI −3.8, 3.7)”

absence[Results, Primary outcome]

Exact p-values are not provided.

PASSReviewer 3· 95% conf

Statistical methods are rigorous and well-reported: tests are named, exact p-values and confidence intervals are provided, multiple imputation is described, and a clear primary analysis is specified.

Evidence

direct quote[Methods, Statistical Analysis]

“We used linear regression with change in KOOS Pain as the primary outcome, adjusting for site, baseline KL grade (0-2 vs. 3), baseline KOOS Pain, and enrollment date (prior to or after March 15, 2020).”

direct quote[Results, Primary outcome]

“The difference in three-month change in KOOS Pain between the Standard PT + Home Exercise + Text Messages and the Home Exercise arms was 2.5 points (98.3% confidence interval (CI) −1.3, 6.2)”

direct quote[Methods, Statistical Analysis]

“We performed multiple imputation (MI) using chained equations, with imputation based on observed data (baseline KL grade, age, sex, BMI, baseline KOOS pain, baseline KOOS ADL, study site) and stratified by treatment group.”

The paper does not include a data availability statement, nor does it mention deposition of data in a repository (e.g., Dryad, Zenodo, or a clinical trial data-sharing platform). The ClinicalTrials.gov registration number is provided but that is a trial registration, not a data repository. Custom code is not mentioned. For a clinical trial, a data availability statement is required; its absence is a significant reporting failure.

Sub-criteria

code sharingNOT REPORTED

accession numbersNOT REPORTED

repository depositNOT REPORTED

data availability statementNOT REPORTED

Per reviewer (3) — the votes behind the verdict

FAILReviewer 1· 95% conf

No data availability statement, repository deposit, accession numbers, or code sharing is reported.

Evidence

absence[Entire paper]

No data availability statement is present.

absence[Entire paper]

No repository deposit is mentioned.

absence[Entire paper]

No code sharing is mentioned.

FAILReviewer 2· 95% conf

No data availability statement is presented, and no code or data are deposited in a public repository, which is a significant shortcoming for a clinical trial.

Evidence

absence[Entire text]

No data availability statement found.

WARNReviewer 3· 80% conf

The trial is registered and data availability is implied by the registration, but no explicit data availability statement or repository deposit is mentioned. Code sharing is not mentioned.

Evidence

absence[Full text]

No data availability statement is presented.

direct quote[Funding section]

“Clinical Trials.gov (http://ClinicalTrials.gov) NCT03059004”

Methods are comprehensive. The trial is registered at ClinicalTrials.gov (NCT03059004). All prespecified primary and secondary outcomes are reported, including null results and adverse events. Limitations are discussed (generalizability, secondary analyses not adjusted for multiplicity). Conclusions are proportional to the evidence. The only gap is the absence of a reporting guideline statement, which is expected for a clinical trial but does not undermine the overall transparency.

Sub-criteria

funding coiADEQUATE

trial registrationADEQUATE

reporting guidelineNOT REPORTED

methods completenessADEQUATE

all outcomes reportedADEQUATE

limitations discussedADEQUATE

conclusions proportionalADEQUATE

Per reviewer (3) — the votes behind the verdict

PASSReviewer 1· 90% conf

The manuscript reports methods in sufficient detail, includes trial registration, discusses limitations, and provides proportional conclusions. However, it does not reference a reporting guideline (e.g., CONSORT).

Evidence

direct quote[Funding and Discussion]

“Clinical Trials.gov (http://ClinicalTrials.gov) NCT03059004 (https://clinicaltrials.gov/ct2/show/NCT03059004)”

direct quote[Discussion]

“Generalizability is limited by the small number of Black, Asian, and Hispanic participants”

direct quote[Discussion and Abstract]

“For patients with degenerative meniscal tear and knee pain, the addition of physical therapy or text messages to encourage adherence to home exercises was not superior in reducing pain to a home exercise program alone.”

PASSReviewer 2· 90% conf

Methods are detailed, trial is registered, limitations are discussed, conclusions are proportional, and funding/COI are reported. The only missing element is a reference to a reporting guideline (e.g., CONSORT).

Evidence

direct quote[Abstract and Methods]

“Clinical Trials.gov (http://ClinicalTrials.gov) NCT03059004”

direct quote[Discussion]

“We note several limitations. Generalizability is limited by the small number of Black, Asian, and Hispanic participants (, ).”

direct quote[Acknowledgements/Disclosures]

“Supported by NIH/NIAMS U01AR071658; R21AR076156; P30AR072577; K01AR075879 (Dr. Collins). ... Disclosure forms provided by the authors are available with the full text of this article at NEJM.org”

PASSReviewer 3· 90% conf

The trial is registered, methods are detailed, limitations are discussed, conclusions are proportional to the evidence, and funding/COI are disclosed.

Evidence

direct quote[Discussion, paragraph 4]

“We note several limitations. Generalizability is limited by the small number of Black, Asian, and Hispanic participants”

direct quote[Funding section and Disclosures]

“Funding: Supported by NIH/NIAMS U01AR071658; R21AR076156; P30AR072577; K01AR075879 (Dr. Collins).”

direct quote[Funding section]

“Clinical Trials.gov (http://ClinicalTrials.gov) NCT03059004”

4 copyedit issues flagged: mostly consistency, punctuation.

Checked 35 references: 28 verified — 7 not checked.

Reproducibility

2 data/code links checked; 1 live.

Registered (1 ID: ClinicalTrials.gov). No reporting guideline cited.

Adcurare Rigor Action ItemsFinal pass before journal submission

The manuscript is substantively rigorous but requires several reporting improvements before submission. The most critical items are adding a data availability statement and an informed consent statement, and reporting exact p-values. The copyedit items are minor but should be addressed.

1.
HIGHdata code
Add a data availability statement in the Methods/Data Sharing section, specifying how de-identified participant data can be accessed (e.g., via a managed-access repository like Vivli or YODA, or upon reasonable request with a data use agreement).
This is a standard requirement for clinical trials; its absence is a reporting failure that could lead to rejection.
2.
HIGHethics
Add an explicit statement in the Methods/Participants section that written informed consent was obtained from all participants.
Informed consent is a mandatory reporting element for human-subjects research; its absence is a fixable but serious gap.
3.
HIGHstatistics
Report exact p-values (e.g., p=0.XX) for all primary and secondary analyses alongside the confidence intervals.
Exact p-values are expected for clinical trials and provide readers with more precise information than threshold statements.
4.
HIGHstatistics
Identify the statistical software package (e.g., SAS, R, Stata) and version used for all analyses in the Statistical Analysis section.
Software identification is a standard reporting expectation that aids reproducibility and verifiability.
5.
MEDIUMreporting
Reference the CONSORT reporting guideline in the Methods or Acknowledgments and indicate that the checklist was followed.
This is a best practice for RCTs and some journals require it; it is currently missing.
6.
MEDIUMreporting
Add a statement describing regulatory compliance (e.g., adhered to the Declaration of Helsinki) in the Methods section.
This is an expected part of ethical reporting for human trials and is currently absent.
7.
MEDIUMdata code
Consider depositing the full trial protocol and statistical analysis plan in a public repository (e.g., ClinicalTrials.gov already contains the registry, but full protocol could be shared).
Sharing the protocol enhances transparency and makes adherence to pre-specifications verifiable.
8.
LOWcopyedit
In the Abstract, Methods, and Results, standardize capitalization of arm names to 'Home Exercise + Text Messages' and 'Home Exercise alone'.
Consistency improves readability and prevents confusion; currently 'Home Exercises' and 'Home Exercise' are used interchangeably.
9.
LOWcopyedit
In the Results, primary outcome section, change 'Home Exercises versus Home Exercise + Text Messages' to 'Home Exercise versus Home Exercise + Text Messages' for consistency.
Minor inconsistency in arm naming could confuse readers.
10.
LOWcopyedit
In Methods, paragraph 2, add a period after 'randomized' to complete the sentence.
Incomplete sentence punctuation is a minor grammatical error.
11.
LOWcopyedit
In Methods, Statistical Analysis, remove the extra comma after 'Rubin’s rules'.
Extra punctuation is a minor typographic error.

Full text (22,579 chars)Analyzed: Jul 6, 2026

Read alongside

A Randomized Trial of Physical Therapy for Meniscal Tear and Knee Pain.

Read full text (PMC)

Journal

DOI

10.1056/NEJMoa2503385

Share this Rigor Review

Post on X Share on LinkedIn Share via Email

Embed this Rigor badge

<a href="https://adcurare.com/verify/84f0b881-e0f2-464b-8392-25b78e8e4dd1" target="_blank" rel="noopener">
  <img src="https://adcurare.com/verify/84f0b881-e0f2-464b-8392-25b78e8e4dd1/badge" alt="Adcurare Rigor Review — 4.25★ (Strong), 0 critical, 4 high issues for “A Randomized Trial of Physical Therapy for Meniscal Tear and Knee Pain.”" width="440" height="104" style="max-width:100%;height:auto" />
</a>

Every embed links back to this Rigor Record.

Record fingerprint

7a5e83ac3bcba30052cd90600ef4ca396d4fadb2a076f48bd962d2de747a0f9e

Verify via API

Issued Jul 6, 2026Engine 7.6.0

Adcurare assesses methodological rigor, not the importance of the findings. See how we evaluate →